There’s a “back-to-the-future” feeling in the current scene in product security and brand integrity: many of the initiatives that were starting up in 2008, when the California e-pedigree program was marching ahead (only to be delayed until 2015), are being […]
Read MoreTranzone Logistics fzco, the subsidiary of Banaja Holdings, has announced that is the first and only specialized company in Jebel Ali Free Zone, U.A.E. to provide storage and handling services of pharmaceuticals and related healthcare products. Storage and handling services […]
Read MoreThe ability to monitor a bulk-freight shipment in transit, using communications technologies like satellite telecommunications or the Global Positioning System (GPS) has been in existence for several years. Now, this technology is being introduced to the pharmaceutical industry as a […]
Read MoreCardinal’s Center for the Advancement of Molecular Imaging (CAMI) had its official opening in July. The facility has paired (dual) cyclotrons that produce radioisotopes, especially those used in positron-emission tomography (PET), from predecessor radiochemicals; a collaboration laboratory that brings Cardinal […]
Read MoreHigher-than-average growth for specialty pharmaceuticals and vaccines, combined with heightened (and more expensive) regulatory requirements for pharma shipping worldwide, added up to a $5.9-billion global market for cold-chain logistics services in 2009, according to the 2nd edition of the Biopharma Cold […]
Read MoreThe typical supply chain process in pharmaceuticals goes something like this: • Ingredients/materials/packaging from suppliers are shipped into a production facility on wood pallets • The goods are removed from the pallets to enter the manufacturing process, then often wind […]
Read MoreThe PDA Cold Chain Management Conference, typically held in March near PDA’s Bethesda, MD headquarters, is one of two annual meetings organized by the Pharmaceutical Cold Chain Interest Group (PCCIG), a voluntary working group of industry technical experts and managers […]
Read MoreFor nearly 30 years, the US Drug Enforcement Administration has required documentation for transactions involved controlled substances, which are primarily pain or neurological products with narcotic effects. The process has added difficult administrative burdens to manufacturers and their trading partners, […]
Read MoreAmerisourceBergen Specialty Group’s ASD healthcare unit (Frisco, TX) chose the recent National Hemophilia Foundation annual meeting to begin showing its Cubixx unit to prospective clients, for possible use in either doctor’s offices or patients’ homes where cold-chain pharmaceuticals would be […]
Read MoreThe European market presents attractive opportunities to life sciences manufacturers, but is characterized by significant challenges as well. Legal, regulatory and cultural differences are present throughout the market that can add to costs or limit market access. Nevertheless, US and […]
Read More
